24 March 2025 : Clinical Research
Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced Cervical Cancer
Dodi Suardi ABE 1, Raden Tina Dewi Judistiani AE 2*, Muhamad Rinaldi E 1, Nurvita Trianasari CD 3, Basuki Hidayat AC 4, Ronny Lesmana AE 5, Rudi Supriyadi AE 6, Syahrul Rauf ABE 7, Budi Setiabudiawan AE 8, Yudi Mulyana Hidayat AE 1, Aisyah Shofiatun Nisa AE 1DOI: 10.12659/MSM.945964
Med Sci Monit 2025; 31:e945964
Table 1 Study patient characteristics.
| Variable | Group | P value | |
|---|---|---|---|
| Treatment (N=69) | Control (N=54) | ||
| Mean±Std | 50.38±9.178 | 49.93±8.659 | 0.786 |
| Median | 50.50 | 49.50 | |
| Range (min–max) | 29.00–72.00 | 26.00–72.00 | |
| Mean±Std | 2.93±1.274 | 3.07±1.338 | 0.673 |
| Median | 3.00 | 3.00 | |
| Range (min–max) | 1.00–6.00 | 1.00–7.00 | |
| Squamous cell carcinoma | 55 (79.7%) | 44 (81.5%) | 1.000 |
| Adenosquamous carcinoma | 14 (20.3%) | 10 (18.5%) | |
| Mean±Std | 109.19±106.617 | 86.58±76.500 | 0.100 |
| Median | 72.47 | 59.22 | |
| Range (min–max) | 11.22–737.55 | 15.27–288.26 | |
| Sufficiency | 8 (11.6%) | 4 (7.4%) | 0.261 |
| Insufficiency | 10 (14.5%) | 14 (25,9%) | |
| Deficiency | 51 (73.9%) | 36 (66.7%) | |
| * Unpaired T-test or Mann-Whitney test for numerical data; ** Chi-Square, Kolmogorov-Smirnov, or Exact Fisher test for categorical data (p | |||